Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Sodium thiosulfate by Byondis for Drug Toxicity: Likelihood of Approval
Sodium thiosulfate is under clinical development by Byondis and currently in Phase II for Drug Toxicity. According to GlobalData, Phase...